Skolnick P[au] - Search Results

Year	Number of Results
1968	2
1970	1
1973	1
1974	2
1975	6
1976	3
1977	3
1978	10
1979	13
1980	16
1981	19
1982	20
1983	13
1984	17
1985	20
1986	27
1987	28
1988	22
1989	20
1990	22
1991	13
1992	21
1993	19
1994	13
1995	15
1996	11
1997	7
1998	14
1999	6
2000	4
2001	9
2002	4
2003	6
2004	3
2005	1
2006	3
2007	4
2008	3
2009	3
2010	1
2011	5
2012	9
2013	3
2014	4
2015	7
2016	6
2017	2
2018	5
2019	5
2020	2
2021	1

1

The Opioid Epidemic: Crisis and Solutions.

Skolnick P. Skolnick P. Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:143-159. doi: 10.1146/annurev-pharmtox-010617-052534. Epub 2017 Oct 2. Annu Rev Pharmacol Toxicol. 2018. PMID: 28968188 Review.

2

On the front lines of the opioid epidemic: Rescue by naloxone.

Skolnick P. Skolnick P. Eur J Pharmacol. 2018 Sep 15;835:147-153. doi: 10.1016/j.ejphar.2018.08.004. Epub 2018 Aug 7. Eur J Pharmacol. 2018. PMID: 30092179 Free article.

3

Countermeasures for Preventing and Treating Opioid Overdose.

France CP, Ahern GP, Averick S, Disney A, Enright HA, Esmaeli-Azad B, Federico A, Gerak LR, Husbands SM, Kolber B, Lau EY, Lao V, Maguire DR, Malfatti MA, Martinez G, Mayer BP, Pravetoni M, Sahibzada N, Skolnick P, Snyder EY, Tomycz N, Valdez CA, Zapf J. France CP, et al. Among authors: skolnick p. Clin Pharmacol Ther. 2021 Mar;109(3):578-590. doi: 10.1002/cpt.2098. Epub 2020 Nov 29. Clin Pharmacol Ther. 2021. PMID: 33113208 Free PMC article. Review.

4

Be positive about negatives-recommendations for the publication of negative (or null) results.

Bespalov A, Steckler T, Skolnick P. Bespalov A, et al. Among authors: skolnick p. Eur Neuropsychopharmacol. 2019 Dec;29(12):1312-1320. doi: 10.1016/j.euroneuro.2019.10.007. Epub 2019 Nov 18. Eur Neuropsychopharmacol. 2019. PMID: 31753777 Free article. Review.

5

Medication development in opioid addiction: Meaningful clinical end points.

Volkow ND, Woodcock J, Compton WM, Throckmorton DC, Skolnick P, Hertz S, Wargo EM. Volkow ND, et al. Among authors: skolnick p. Sci Transl Med. 2018 Mar 28;10(434):eaan2595. doi: 10.1126/scitranslmed.aan2595. Sci Transl Med. 2018. PMID: 29593105 Review.

6

Cannabinoid₁ (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose.

Skolnick P, Crystal R. Skolnick P, et al. J Neural Transm (Vienna). 2020 Feb;127(2):279-286. doi: 10.1007/s00702-019-02132-7. Epub 2019 Dec 31. J Neural Transm (Vienna). 2020. PMID: 31893308 Free PMC article. Review.

7

The development of glutamate-based antidepressants is taking longer than expected.

Garay R, Zarate CA Jr, Cavero I, Kim YK, Charpeaud T, Skolnick P. Garay R, et al. Among authors: skolnick p. Drug Discov Today. 2018 Oct;23(10):1689-1692. doi: 10.1016/j.drudis.2018.02.006. Epub 2018 Mar 1. Drug Discov Today. 2018. PMID: 29501913 Free PMC article. No abstract available.

8

Glutamate-based antidepressants: preclinical psychopharmacology.

Pilc A, Wierońska JM, Skolnick P. Pilc A, et al. Among authors: skolnick p. Biol Psychiatry. 2013 Jun 15;73(12):1125-32. doi: 10.1016/j.biopsych.2013.01.021. Epub 2013 Feb 28. Biol Psychiatry. 2013. PMID: 23453290 Review.

9

Biologic Approaches to Treat Substance-Use Disorders.

Skolnick P. Skolnick P. Trends Pharmacol Sci. 2015 Oct;36(10):628-635. doi: 10.1016/j.tips.2015.07.002. Trends Pharmacol Sci. 2015. PMID: 26435208 Free PMC article. Review.

10

Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.

Krieter P, Gyaw S, Crystal R, Skolnick P. Krieter P, et al. Among authors: skolnick p. J Pharmacol Exp Ther. 2019 Nov;371(2):409-415. doi: 10.1124/jpet.118.256115. Epub 2019 Apr 2. J Pharmacol Exp Ther. 2019. PMID: 30940694 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results